ABB commissions ACS560 drives at Bharat Biotech’s facility for safe manufacturing of Covaxin

ABB India President (Drive Products) A R Madhusudan added that since domestic production of medicine and vaccines has become imperative at this stage of the pandemic, the company’s endeavour is to support its customers and other stakeholders with its products and solutions and ease the process.